While pharma peers stumble, AbbVie defeated the patent cliff

More in Business

• Paradise under pressure: Can Philippines’ Siargao sustain its tourism boom?

  Rapid development on the popular Philippine island is threatening community stability as annual tourist arrivals outpace the local population by nearly four to one. Following recoveries from a major typhoon and pandemic closures, the destination has seen soaring rents, mounting waste, and higher costs of living. Residents and business owners now worry that unchecked expansion will permanently displace them despite the recent economic windfalls.

  11 min read
• David Jones’s finances were reviewed and restructuring flagged months before it fell into administration

  Behind-the-scenes scrutiny began half a year prior to the department store's collapse, revealing that owner Anchorage Capital had engaged financial specialists well before the public failure. Small suppliers and voucher-holding shoppers face substantial financial exposure after the retailer prolonged payment schedules while continuing to order stock. The business is currently being maintained under external oversight while administrators seek a viable acquisition or capital injection.

  2 min read
• Opinion: STAT+: BIO CEO: American biotech needs a coordinated plan to beat China — now

  Beijing has designated biotechnology as a national pillar industry in an explicit bid to overtake the United States as the global sector leader. In response, domestic industry leadership is calling for an urgent, comprehensive strategy to safeguard a critical innovation pipeline that underpins both healthcare access and biological defense capabilities. Failing to protect this competitive advantage threatens to weaken a foundational economic pillar that generates trillions of dollars annually.

  1 min read